S. Postma

发表

The extent of ST elevation and ST deviation as predictors of mortality in ST-segment elevation myocardial patients planned to undergo primary percutaneous coronary intervention.

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2016, International journal of cardiology.

Prehospital triage and risk assessment in STEMI patients

S. Postma, 2015 .

Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction.

D. Postma, C. Wijmenga, M. Viergever, 2013, Atherosclerosis.

Field triage in the ambulance versus referral via non-percutaneous coronary intervention centre in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A systematic review

H. Suryapranata, E. Jansma, G. De Luca, 2017, European heart journal. Acute cardiovascular care.

The influence of residential distance on time to treatment in ST-elevation myocardial infarction patients

J. Ottervanger, H. Suryapranata, M. de Boer, 2014, Netherlands Heart Journal.

Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.

V. Fuster, J. Ottervanger, F. Fernández‐Avilés, 2016, Journal of the American College of Cardiology.

Final results of the Randomised Evaluation of short-term DUal antiplatelet therapy in patients with acute Coronary syndromE treated with a new generation stent (REDUCE) trial.

H. Suryapranata, G. De Luca, S. Damen, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial.

H. Suryapranata, D. Dudek, G. De Luca, 2021, Atherosclerosis.

Early ambulance initiation versus in-hospital initiation of high dose clopidogrel in ST-segment elevation myocardial infarction

J. Ottervanger, H. Suryapranata, J. T. ten Berg, 2014, Thrombosis and Haemostasis.

Beta-blocker effect on ST-segment: a prespecified analysis of the EARLY-BAMI randomised trial

V. Fuster, J. Ottervanger, F. Fernández‐Avilés, 2020, Open Heart.

Predictors and outcome of grade 3 ischemia in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

H. Suryapranata, Y. Birnbaum, C. Hamm, 2011, Journal of electrocardiology.

The influence of system delay on 30-day and on long-term mortality in patients with anterior versus non-anterior ST-segment elevation myocardial infarction: a cohort study

J. Ottervanger, H. Suryapranata, J. T. ten Berg, 2015, Open Heart.

Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial

H. Suryapranata, G. De Luca, A. V. Van't Hof, 2021, Journal of Thrombosis and Thrombolysis.

Short‐term dual antiplatelet therapy in diabetic patients admitted for acute coronary syndrome treated with a new‐generation drug‐eluting stent

H. Suryapranata, G. De Luca, M. Verdoia, 2022, Diabetes/metabolism research and reviews.

Pharmacokinetics, pharmacodynamics, and tolerability of subcutaneous administration of a novel glycoprotein IIb/IIIa inhibitor, RUC-4, in patients with ST-segment elevation myocardial infarction.

C. Granger, B. Coller, C. Gibson, 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A comparison between the Plateletworks-assay and light transmittance aggregometry for monitoring the inhibitory effects of clopidogrel.

J. T. ten Berg, H. Bouman, J. V. van Werkum, 2010, International journal of cardiology.

An Observational Study on the Effects of Nadroparin-Based and Citrate-Based Continuous Venovenous Hemofiltration on Calcium Metabolism

P. V. D. van der Voort, S. Postma, E. Boerma, 2007, Blood Purification.

Pre-hospital diagnosis, triage and treatment in patients with ST elevation myocardial infarction

T. Bergmeijer, J. T. ten Berg, S. Postma, 2012, Heart.

Pre-hospital treatment with zalunfiban (RUC-4) in patients with ST- Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Rationale and design of the CELEBRATE trial.

C. Granger, J. Bosch, G. Montalescot, 2022, American heart journal.

Prehospital treatment of ST-segment elevated myocardial infarction patients.

T. Bergmeijer, J. T. ten Berg, S. Postma, 2013, Future cardiology.

Prehospital triage in the ambulance reduces infarct size and improves clinical outcome.

J. Ottervanger, H. Suryapranata, M. de Boer, 2011, American heart journal.

Predictors and outcome of grade 3 ischemia in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

H. Suryapranata, Y. Birnbaum, C. Hamm, 2011, Journal of electrocardiology.

Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel

F. Verheugt, J. T. ten Berg, J. Kelder, 2008, Thrombosis and Haemostasis.

The influence of system delay on 30-day and on long-term mortality in patients with anterior versus non-anterior ST-segment elevation myocardial infarction: a cohort study

J. Ottervanger, H. Suryapranata, J. T. ten Berg, 2015, Open Heart.